Table 3.
Patient management characteristics
| Number | Mean ± SD | Range | |
|---|---|---|---|
| LOS in ED (hours) | 97 | 13.35 ± 17.154 | 1.00–137.50 |
| LOS in ICU (days) | 43 | 12.04 ± 13.951 | 0.40–70.67 |
| LOS in GPU (days) | 52 | 7.27 ± 5.941 | 0.33–30.95 |
| LOS in the hospital (days) | 97 | 13.86 ± 13.618 | 0.507–70.917 |
| Time to vasopressors in the first 24 h (hours) | 21 | 9.14 ± 8.027 | 0.50–24.00 |
| Time to norepinephrine (hours)a | 36 | 148.20 ± 282.190 | 1–1464.00 |
| Time to dopamine (hours)a | 7 | 278.31 ± 393.557 | 1–870.50 |
| Time to dobutamine (hours) | 4 | 59.50 ± 41.026 | 22–114.50 |
| Vasopressors Tx duration (days) for those who took vasopressors in the first 24 h | 21 | 3.33 ± 3.411 | 0.13–12.88 |
| Steroid Tx duration (days) | 47 | 7.55 ± 7.540 | 0.50–35.00 |
| Time to antibiotic treatment initiation (hours)a | 96 | 3.43 ± 4.479 | 0.167–36.33 |
| IV fluid requirement first 6 h (liters) | 96 | 1.75 ± 1.964 | 0.02–11.06 |
| IV fluid requirement first 24 h (liters) | 96 | 3.37 ± 2.846 | 0.160–16.642 |
aThe time to norepinephrine, to dopamine, and to antibiotic treatment for one patient is missing since the paper containing this information was not found in the patient’s chart